Prosecution Insights
Prosecution Insights
4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JAVANMARD, SAHAR | 2 | 65.3% | +35.6% |
| HERNANDEZ, JACKSON J | 1 | 52.8% | +51.5% |
| SANCHEZ, JUSTIN CHRISTOPHER | 1 | 86.5% | +11.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17795402 | COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH | SANCHEZ, JUSTIN CHRISTOPHER | 91d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18085792 | THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE | JAVANMARD, SAHAR | 142d overdue |
| 17795402 | COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH | SANCHEZ, JUSTIN CHRISTOPHER | 91d overdue |
| 18005012 | COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH | HERNANDEZ, JACKSON J | 78d overdue |
| 17989006 | METHODS AND COMPOSITIONS FOR TREATING ABNORMAL CELL GROWTH | JAVANMARD, SAHAR | — |
| Art Unit | Apps |
|---|---|
| 1622 | 3 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18005012 | COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH | HERNANDEZ, JACKSON J | 1627 | Other | Final Rejection | 78d overdue | Pending | Jan 10, 2023 |
| 18085792 | THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE | JAVANMARD, SAHAR | 1622 | §103 | Non-Final OA | 142d overdue | Pending | Dec 21, 2022 |
| 17989006 | METHODS AND COMPOSITIONS FOR TREATING ABNORMAL CELL GROWTH | JAVANMARD, SAHAR | 1622 | §103 | Final Rejection | — | Pending | Nov 17, 2022 |
| 17795402 | COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §103 | Non-Final OA | 91d overdue | Pending | Jul 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial